Topics

Genix Acquires 30 Ophthalmic Dossiers In Canada

06:21 EST 14 Feb 2020 | SCRIP

Canadian firm Genix has acquired 30 ophthalmic generic dossiers from Canagen. Genix expects to begin commercialization from 2022.

      

Related Stories

 

Original Article: Genix Acquires 30 Ophthalmic Dossiers In Canada

NEXT ARTICLE

More From BioPortfolio on "Genix Acquires 30 Ophthalmic Dossiers In Canada"

Quick Search

Relevant Topic

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...